跳转至内容
Merck
CN

SML3372

Glutipyran

≥98% (HPLC)

别名:

rel-N-(3,4-Dimethoxybenzyl)-N-((R)-3-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-3-phenylpropyl)furan-2-carboxamide

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C30H37NO5
分子量:
491.62
UNSPSC Code:
12352200
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

shipped in

dry ice

storage temp.

-10 to -25°C

Quality Level

Biochem/physiol Actions

Broad-spectrum potent and selective glucose transporter (GLUT) inhibitor
Glutipyran is a broad-spectrum potent and selective glucose transporter (GLUT) inhibitor that targets both GLUT1 and GLUT3. Glutipyran inhibits glycolytic activity and cell growth in PANC-1 cells (IC50 = 1.9 µM). It exhibits antitumor activity (12.5 mg/kg, i.v.) once daily in MIA PaCa-2 xenograft mouse model.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Makoto Kawatani et al.
ACS chemical biology, 16(8), 1576-1586 (2021-07-24)
Cancer cells reprogram their metabolism to survive and grow. Small-molecule inhibitors targeting cancer are useful for studying its metabolic pathways and functions and for developing anticancer drugs. Here, we discovered that glutipyran and its derivatives inhibit glycolytic activity and cell

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持